Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT05036083

Completed

Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion

Breast Carcinoma | Invasive Breast Carcinoma
NCT03588091

Completed

Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer

HER2-positive Breast Cancer
NCT05625087

Active, not recruiting

Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib (SAFIR 03)

Breast Cancer Stage IV
NCT07115095

Completed

Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer

HER2-positive Breast Cancer
NCT02792114

Active, not recruiting

T-Cell Therapy for Advanced Breast Cancer

Breast Cancer | Metastatic HER2-negative Breast
NCT02605486

Active, not recruiting

Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer (MBC)
NCT03747120

Active, not recruiting

Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]

Breast Cancer | HER2-positive Breast Cancer
NCT06982391

Enrolling by invitation

Compassion, Social Support, Flexibility, and Resilience Program for Women Surviving Breast Cancer (ReACT)

Mastectomy | Breast Cancer Survivor
NCT03324425

Active, not recruiting

Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer (SIMPHONY)

Breast Cancer Stage IV
NCT01958021

Completed

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer (MONALEESA-2)

Advanced, Metastatic Breast Cancer
NCT03575065

Completed

Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China

HER2-negative Breast Cancer
NCT00542451

Completed

Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer

Breast Cancer | Carcinoma of the Breast
NCT06433804

Completed

Clinicopathological Parameters of HER2 Low Breast Cancers

HER2 Low Breast Cancers
NCT05033756

Active, not recruiting

Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO (COMPRENDO)

Breast Cancer | Malignant Neoplasm of Breast
NCT06107790

Completed

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast Cancer

HER2-positive Breast Cancer
NCT03329378

Terminated

Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer

Locally Advanced Breast Cancer
NCT01242800

Completed

Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer

Breast Cancer | Stage IV Breast Cancer
NCT04896320

Withdrawn

Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. (2019-101826)

Breast Cancer Stage IV
NCT05750693

Active, not recruiting

PIK3CA in HER2+ BC and pCR Trial

HER2-positive Breast Cancer
NCT03510988

Terminated

Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer

Newly Diagnosed Breast Cancer
NCT03386162

Terminated

SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer (SAFIR-PI3K)

Breast Cancer, PI3K, Alpelisib
NCT03948568

Completed

Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT) (REaCT-RETT)

Early-stage Breast Cancer
NCT04222426

Terminated

89Zr-atezolizumab PET Scan and Lobular Breast Cancer (ImaGelato)

Lobular Metastatic Breast Cancer
NCT03261323

Withdrawn

Breast Reconstruction Following Breast Cancer in Very High Risk Patients

Breast Cancer | Malignant Neoplasm of Breast
NCT02400567

Completed

Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women (NeoPAL)

Neoadjuvant Operable Breast Cancer
NCT02600923

Completed

Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

Advanced Breast Cancer Female
NCT03281824

Completed

Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients

HER2-positive Breast Cancer
NCT01705691

Completed

Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer

Breast Cancer | HER2-negative Breast Cancer
NCT04798976

Unknown

Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer

Breast Cancer-specific Survival
NCT04756921

Completed

18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response

HER2-positive Breast Cancer
NCT03684135

Completed

Satisfaction Assessment of Patients With Local Breast Cancer When Using Cosmetics During Chemotherapy and Post-treatment Thermal Cure (COSMIK)

Local Breast Cancer Patients
NCT00309569

Completed

Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients

Early Stage Breast Cancer
NCT01162200

Completed

Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer

Early Stage Breast Cancer
NCT03201913

Completed

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

Metastatic ER+ Breast Cancer
NCT04499118

Unknown

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

HER2-negative Breast Cancer
NCT03140553

Completed

TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer (neoCARH)

HER2-Positive Breast Cancer
NCT02362958

Completed

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

HER2 Positive Breast Cancer
NCT01855828

Completed

Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer

Her2-Positive Breast Cancer
NCT01545648

Terminated

Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer

Early Stage Breast Cancer
NCT04094896

Unknown

TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer

HER2-Positive Breast Cancer
NCT04034823

Unknown

KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer

HER2-positive Breast Cancer
NCT02005887

Completed

TRial on the Endocrine Activity of Neoadjuvant Degarelix (TREND)

Breast Cancer Invasive Nos
NCT03944226

Unknown

Is Dietary Nitrate Effective in Reducing Aerobic Glycolysis in Breast Cancer? (BEET)

Malignant Breast Tissue Neoplasm
NCT03908749

Unknown

A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2

HER2 Positive Breast Carcinoma
NCT03847818

Unknown

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer

HER2-positive Breast Cancer
NCT01598285

Terminated

A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer

Breast Cancer Invasive Nos
NCT02511301

Unknown

Circadian Thermal Sensing to Detect Breast Disease

Early-Stage Breast Carcinoma
NCT03045393

Withdrawn

Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC (IMGN853)

Breast Cancer Triple Negative
NCT03271853

Suspended

Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.

Breast Neoplasm Female | Cancer, Breast | Thermography
NCT03003611

Completed

Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer

Early Stage Breast Carcinoma

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations